RxDoctor Payments Data

Kyle Cabbell, MD

Neurological Surgery · Greensboro, NCNPI 1598756934

Payments from drug & device makers

$2,518in general payments, 2019–2025

Across 56 payments — averaging $44.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$1K
  • Stryker$170
  • Arbor Pharmaceuticals, Inc.$157
  • AstraZeneca$130
  • Providence Medical Technology, Inc.$110
  • Boston Scientific$101
  • plus $501 from 14 others

What the payments were for

  • Travel & lodging$90036%
  • Food & beverage$1,58663%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,518 in reported general payments places this provider in the 35th percentile of 196 neurological surgery providers in North Carolina.

See all neurological surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$60,438
Medicare patients
118
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate11$8,052
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$1,449
Oxycodone Hcl98$1,215
Tizanidine Hcl73$537
Cyclobenzaprine Hcl32$412
Gabapentin41$383
Methocarbamol15$227
Tramadol Hcl42$190
Methylprednisolone15$101
Diazepam16$18

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$13$8,05211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 196 neurological surgery providers in North Carolina.

Other neurological surgery in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →